Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetic/Pharmacodynamic Study of Vicagrel Capsules and Clopidogrel Tablets in Healthy CYP2C19 Normal Metabolizers

NCT07067775 is registered in ClinicalTrials.gov with Jiangsu vcare pharmaceutical technology co., LTD as lead sponsor.

NCT NCT07067775
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07067775 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetic/Pharmacodynamic Study of Vicagrel Capsules and Clopidogrel Tablets in Healthy CYP2C19 Normal Metabolizers
Lead sponsor
Jiangsu vcare pharmaceutical technology co., LTD
Phase
Phase 1
Overall status
Completed
Start date
August 5, 2025
Completion date
August 22, 2025
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome